ASSOCIATION OF LEPTIN LEVEL AND ERYTHROPOIESIS-STIMULATING AGENTS HYPORESPONSIVNESS IN CHRONIC HEMODIALYSIS PATIENTS

被引：0
作者：
Vlatkovic, Vlastimir [1 ]
Risovic, Ivona [1 ]
Popovic-Pejicic, Snjezana [1 ]
Vojvodic, Dragan [1 ]
机构：
[1] Univ Clin Ctr Republ Srpska, Banja Luka, Bosnia & Herceg
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP375
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Lower serum magnesium level is an important risk factor for erythropoiesis-stimulating agents hypo-responsiveness in hemodialysis patients
    Hebah, Hayam
    Abdelmegied, Shaimaa
    Osman, Dina
    Khedr, Lina
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2025, 37 (01)
  • [42] The effect of altitude on erythropoiesis-stimulating agent dose, hemoglobin level, and mortality in hemodialysis patients
    Scott Sibbel
    Bradley J. Maroni
    Steven M. Brunelli
    Journal of Nephrology, 2017, 30 : 821 - 829
  • [43] Use and cost of erythropoiesis-stimulating agents in patients with cancer
    Daniel, Gregory
    Hurley, Dana
    Whyte, Joanna L.
    Willey, Vincent
    Wilson, Marcus
    Kallich, Joel
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (07) : 1775 - 1784
  • [44] Responsiveness to an erythropoiesis-stimulating agent is correlated with body composition in patients undergoing chronic hemodialysis
    Lee, Hyang Yun
    Suh, Suk-Won
    Hwang, Jin Ho
    Shin, Jungho
    FRONTIERS IN NUTRITION, 2022, 9
  • [45] Erythropoiesis-stimulating agents in congestive heart failure patients
    Robles Perez-Monteoliva, Nicolas Roberto
    Macias Nunez, Juan Francisco
    Perez de Villar, Julio Herrera
    MEDICINA CLINICA, 2014, 142 (05): : 215 - 218
  • [46] Erythropoiesis-stimulating agents: the present situation
    Mario Dicato
    Clinical and Translational Oncology, 2011, 13 : 287 - 288
  • [47] HEPATIC ERYTHROPOIETIN SYNTHESIS IS ENHANCED IN HEMODIALYSIS PATIENTS WHO DO NOT REQUIRE ERYTHROPOIESIS-STIMULATING AGENTS
    Hirayama, Aki
    Yanagawa, Takamoto
    Kaneko, Yoko
    Nagano, Yumiko
    Owada, Shigeru
    Ishizu, Takashi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1178 - 1178
  • [48] Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents
    Haase, Volker H.
    Chertow, Glenn M.
    Block, Geoffrey A.
    Pergola, Pablo E.
    deGoma, Emil M.
    Khawaja, Zeeshan
    Sharma, Amit
    Maroni, Bradley J.
    McCullough, Peter A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (01) : 90 - 99
  • [49] Glycan analysis of erythropoiesis-stimulating agents
    Cowper, Ben
    Laven, Martin
    Hakkarainen, Birgit
    Mulugeta, Ezra
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2020, 180
  • [50] Erythropoiesis-stimulating agents in cancer - Reply
    Rizzo, J. Douglas
    Somerfield, Mark R.
    Hagerty, Karen L.
    Seidenfeld, Jerome
    Bohlius, Julia
    Bennett, Charles L.
    Cella, David F.
    Djulbegovic, Benjamin
    Goode, Matthew J.
    Jakubowski, Ann A.
    Miller, Carole B.
    Rarick, Mark U.
    Regan, David H.
    Lichtin, Alan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (18) : 3098 - 3100
12345